Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Charlotte Wagner

Concepts (73)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asparaginase
1
2026
34
0.950
Why?
Hodgkin Disease
2
2023
173
0.850
Why?
Immunotherapy, Adoptive
5
2026
356
0.830
Why?
Multiple Myeloma
5
2026
310
0.830
Why?
Etoposide
1
2024
169
0.800
Why?
Cyclophosphamide
1
2024
275
0.780
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2026
299
0.750
Why?
Oligopeptides
1
2024
264
0.720
Why?
Cisplatin
1
2024
347
0.710
Why?
Immunoconjugates
1
2023
138
0.700
Why?
Dexamethasone
1
2024
368
0.700
Why?
Patient Care Team
1
2026
701
0.630
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2024
1998
0.460
Why?
Antineoplastic Agents
1
2026
2219
0.430
Why?
B-Cell Maturation Antigen
2
2025
17
0.420
Why?
Anemia, Aplastic
2
2025
42
0.410
Why?
Stem Cell Transplantation
2
2026
190
0.390
Why?
Review Literature as Topic
1
2026
53
0.240
Why?
Antilymphocyte Serum
1
2025
55
0.220
Why?
Antibodies, Bispecific
1
2025
70
0.210
Why?
Paraproteinemias
1
2024
5
0.210
Why?
Antigens, CD19
1
2025
137
0.210
Why?
Idarubicin
1
2023
5
0.200
Why?
Anaphylaxis
1
2025
105
0.200
Why?
Receptors, G-Protein-Coupled
1
2025
233
0.190
Why?
Lymphoma, Large B-Cell, Diffuse
1
2025
195
0.190
Why?
Peripheral Nervous System Diseases
1
2023
135
0.180
Why?
Recurrence
1
2024
1133
0.160
Why?
Treatment Outcome
3
2024
11821
0.160
Why?
Retrospective Studies
7
2026
17438
0.140
Why?
Drug Resistance, Neoplasm
1
2024
893
0.140
Why?
Simeprevir
1
2018
5
0.130
Why?
Heterocyclic Compounds, 3-Ring
1
2018
44
0.130
Why?
Chronic Disease
1
2023
1827
0.130
Why?
Protease Inhibitors
1
2018
103
0.130
Why?
HIV Integrase Inhibitors
1
2018
80
0.120
Why?
Neoplasm Recurrence, Local
1
2023
1160
0.120
Why?
Leukemia, Myeloid, Acute
1
2023
702
0.120
Why?
Humans
14
2026
146342
0.120
Why?
Aged
6
2026
26432
0.120
Why?
Middle Aged
6
2026
36619
0.100
Why?
Male
7
2026
73396
0.070
Why?
Female
7
2026
79499
0.070
Why?
United States
1
2026
16136
0.070
Why?
Adult
7
2026
41087
0.070
Why?
Quality-Adjusted Life Years
1
2025
122
0.060
Why?
Staurosporine
1
2023
22
0.050
Why?
Infusions, Intravenous
1
2025
432
0.050
Why?
Cytarabine
1
2023
66
0.050
Why?
Benzoates
1
2023
48
0.050
Why?
Horses
1
2025
229
0.050
Why?
Hydrazines
1
2023
37
0.050
Why?
fms-Like Tyrosine Kinase 3
1
2023
52
0.050
Why?
Multicenter Studies as Topic
1
2025
417
0.050
Why?
Remission Induction
1
2023
308
0.050
Why?
Aged, 80 and over
2
2025
8391
0.050
Why?
Pyrazoles
1
2023
517
0.040
Why?
Immunosuppressive Agents
1
2023
829
0.040
Why?
Oxazines
1
2018
36
0.030
Why?
Area Under Curve
1
2018
335
0.030
Why?
Incidence
1
2023
2936
0.030
Why?
Hepacivirus
1
2018
237
0.030
Why?
Pyridones
1
2018
210
0.030
Why?
Piperazines
1
2018
368
0.030
Why?
Hepatitis C
1
2018
251
0.030
Why?
Drug Therapy, Combination
1
2018
1036
0.030
Why?
Cohort Studies
1
2025
6077
0.030
Why?
Mutation
1
2023
4093
0.020
Why?
HIV-1
1
2018
913
0.020
Why?
Young Adult
1
2025
14330
0.020
Why?
Prospective Studies
1
2018
8123
0.010
Why?
Animals
1
2025
38107
0.010
Why?
HIV Infections
1
2018
3215
0.010
Why?
Wagner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)